Clin2
NCT06452498Possibly a fitNot yet recruiting

Metformin for Preterm Preeclampsia: A Dutch Study

Pre-Eclampsia Onset Less Than 37 WeeksPre-EclampsiaPre-Eclampsia; Complicating PregnancyPre-Eclampsia as Antepartum ConditionPre-eclampsia or Eclampsia With Pre-existing HypertensionPre-Eclampsia; Affecting FetusHELLP Syndrome Complicating PregnancyHELLP Syndrome

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This trial tests if giving metformin (a diabetes medicine) can help people with preterm preeclampsia delay delivery and improve outcomes for both mother and baby. It's for those who are 23 to 31 weeks pregnant and not planning immediate delivery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
180 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are pregnant with one baby (not twins).
  • You are between 23 weeks and 31 weeks + 6 days pregnant.
  • You have been diagnosed with preterm preeclampsia (high blood pressure and protein in urine).
  • The baby is estimated to weigh more than 400 grams (about 14 ounces).
  • You and your doctor have not decided to deliver the baby immediately.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05746793Recruiting
IVF pregnancy study to prevent pre-eclampsia in high-risk women

This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.

Brussels
NCT06340152Recruiting
Studying maternal health after preeclampsia

This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.

San Diego, California
NCT07151339Recruiting
Preventing heart and kidney issues after preeclampsia

This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.

Kiel
NCT06033131Recruiting· Phase 3
Metformin to help prolong pregnancy in preterm preeclampsia

This trial tests whether metformin, a common diabetes medication, can help women with preeclampsia stay pregnant longer before delivery. If you have been diagnosed with preeclampsia and your doctors are monitoring you without immediate delivery, this study might be an option.

Helsinki
NCT05676476Recruiting
Tested extra blood-pressure control to extend pregnancy in preeclampsia

This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.

Birmingham, Alabama
NCT06064669Recruiting
Metformin for healthy live birth in women with prediabetes

This study tests if metformin, a drug that helps control blood sugar, can improve the chance of a healthy live birth in women with prediabetes who are doing in vitro fertilization (IVF). It aims to see if treating prediabetes before and during early pregnancy leads to better outcomes.

Jinan, Shandong

Hear when a new Pre-Eclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.